A mild acute hemolytic transfusion reaction in a patient with alloanti-Ge3: A case report and review of the literature

Transfusion

Volumn 51, Issue 9, 2011, Pages 1966-1971

  Baughn, Mariah R ^a   Whitacre, Patricia ^a   Lo, Grace S ^a   Pandey, Suchitra ^a   Lane, Thomas A ^a  

^a UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ALLOANTIBODY; ANTIGEN; BILIRUBIN; GERBICH 1 ANTIBODY; GERBICH 2 ANTIBODY; GERBICH 2 ANTIGEN; GERBICH 3 ANTIBODY; GERBICH 3 ANTIGEN; GERBICH ANTIGEN; HEMOGLOBIN; IMMUNOGLOBULIN; METHYLPREDNISOLONE; PARACETAMOL; UNCLASSIFIED DRUG;

ADULT; ANTIBODY DETECTION; BILIRUBIN BLOOD LEVEL; BLOOD TRANSFUSION REACTION; CASE REPORT; CELL ASSAY; CELL SURVIVAL; COOMBS TEST; CORTICOSTEROID THERAPY; ERYTHROCYTE TRANSFUSION; ESOPHAGUS VARICES; FEMALE; GASTROINTESTINAL HEMORRHAGE; HEMATEMESIS; HEMOGLOBIN BLOOD LEVEL; HOSPITAL ADMISSION; HUMAN; HUMAN CELL; MONOCYTE; REVIEW;

ADULT; BLOOD TRANSFUSION; ERYTHROCYTE TRANSFUSION; FEMALE; GLYCOPHORIN; HEMOLYSIS; HUMANS; ISOANTIBODIES;

EID: 80052551128     PISSN: 00411132     EISSN: 15372995     Source Type: Journal    
DOI: 10.1111/j.1537-2995.2011.03093.x     Document Type: Review

References (23)

1. Daniels G,. Other blood groups. In:, Roback JD, Combs MR, Grossman BJ, Hillyer CD, editors. Technical manual. 16th ed. Bethesda (MD): American Association of Blood Banks; 2008. p. 429-30.
2. Sacks DA, Johnson CS, Platt LD,. Isoimmunization in pregnancy to Gerbich antigen. Am J Perinatol 1985; 2: 208-10. (Pubitemid 16237235)
3. Arndt PA, Garratty G, Daniels G, Green CA, Wilkes AM, Hunt P, Do J, Glenn S, Peterson D,. Late onset neonatal anemia due to maternal anti-Ge: possible association with destruction of erythroid progenitors. Transfus Med 2005; 15: 125-32. (Pubitemid 40663543)
4. Shulman IA, Thomson JC, Nelson JM, Vengelen-Tyler V, Branch DR,. Autoanti-Gerbich causing severe autoimmune hemolytic anemia [abstract]. Transfusion 1985; 25: 447.
5. Reynolds MV, Vengelen-Tyler V, Morel PA,. Autoimmune hemolytic anemia associated with autoanti-Ge. Vox Sang 1981; 41: 61-7. (Pubitemid 11052290)
6. Selleng S, Selleng K, Zawadzinski C, Wollert HG, Yürek S, Greinacher A,. Management of emergency cardiac surgery in a patient with alloantiGe2. Transfus Med 2009; 19: 50-2.
7. Hildebrandt M, Hell A, Etzel F, Genth R, Salama A,. Determination and successful transfusion of anti-Gerbich-positive red blood cells in a patient with a strongly reactive anti-Gerbich antibody. Infusionsther Transfusionsmed 2000; 27: 154-6. (Pubitemid 30413533)
8. Hadley A, Wilkes A, Poole J, Arndt P, Garratty G,. A chemiluminescence test for predicting the outcome of transfusing incompatible blood. Transfus Med 1999; 9: 337-42.
9. Mochizuki T, Newlon T, Ramsey G,. In vivo cross-match by chromium-51 urinary excretion from labeled erythrocytes: a case of anti-Gerbich. J Nucl Med 1990; 31: 2042-4.
10. Issitt PD, Gutgsell NS, Hervis L,. Some stored antibodies give unreliable results in the monocyte monolayer assay. Transfusion 1988; 28: 399-400.
11. Tilley CA, Crookston MC, Haddad SA, Shumak M,. Red blood cell survival studies in patients with anti-Ch, anti-Yk, anti-Ge, and anti-Vel. Transfusion 1977; 17: 169-72. (Pubitemid 8135732)
12. Nunn HD, Giles CM, Seidl S,. Anti-Ge, as a transfusion problem. Vox Sang 1967; 13: 23-6.
13. Fermepin GH, Perez-Prado A, De Pippig F, Brito J, De Avena CS,. Anti-Ge in a transfused male. Vox Sang 1968; 14: 228-9.
14. Nance SJ, Arndt P, Garratty G,. Predicting the clinical significance of red cell alloantibodies using a monocyte monolayer assay. Transfusion 1987; 27: 449-52. (Pubitemid 18006480)
15. Durán-Suárez JR, Sánchez C, Herrero E, Hernández Sánchez JM,. Anti-Ge2 in a Ge: -2, -3 patient. Sangre (Barc) 1991; 36: 319-21.
16. Pearson HA, Richards VL, Wylie BR, Bruce D, Watt JM, Wilkie D, Kronenberg H,. Assessment of clinical significance of anti-Ge in an untransfused man. Transfusion 1991; 31: 257-9.
17. Daniels G, Poole J, de Silva M, Callaghan T, MacLennan S, Smith N,. The clinical significance of blood group antibodies. Transfus Med 2002; 12: 287-95. (Pubitemid 35178097)
18. Arndt PA, Garratty G,. A retrospective analysis of the value of monocyte monolayer assay results for predicting the clinical significance of blood group alloantibodies. Transfusion 2004; 44: 1273-81. (Pubitemid 39129237)
19. Kohan AI, Reybaud JF, Salamone HJ, Rey JA, Rey CE, Villaravid N, Papa S, Cyrulik Goldztein S, Calahonra R, Sanchez Avalos JC,. Management of a severe transfusional problem in a patient with alloantibody to Kpb (K4). Vox Sang 1990; 59: 216-7.
20. Woodcock BE, Walker S, Adams K,. Case report: hemolytic transfusion reaction-successful attenuation with methylprednisolone and high dose immunoglobulin. Clin Lab Haematol 1993; 15: 59-61. (Pubitemid 23091655)
21. Kohan AI, Niborski RC, Rey JA, Amerise G, Vázquez MI, Zani N, Calahonra R, Binaghi A, Sánchez Avalos J,. High-dose intravenous immunoglobulin in non-ABO transfusion incompatibility. Vox Sang 1994; 67: 195-8. (Pubitemid 24247539)
22. Win N, New H, Lee E, de la Fuente J,. Hyperhemolysis syndrome in sickle cell disease: a case report (recurrent episode) and literature review. Transfusion 2008; 48: 1231-8. (Pubitemid 351793504)
23. Win N, Sinha S, Lee E, Mills W,. Treatment with intravenous immunoglobulin and steroids may correct severe anemia in hyperhemolytic transfusion reactions: case report and literature review. Transfus Med Rev 2010; 24: 64-7.